Nifty

:

22620.40

Sensex

:

73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22620.40
73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

55/99

BSE: 540596 | NSE: ERIS

Watchlist

NSE BSE

892.95

26-Apr-2024

Open
High
Low
Previous Close

884.60
897.30
875.00
883.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

58767
522.68
971.90
605.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

12,143.60
31.42
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

12,754.09
0.82%
4.83

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.72
11.40
11.62

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.43
9.24
4.50

PAT CAGR (%)

10 Years
5 Years
3 Years

18.37
5.62
2.48

P:E (Median)

8 Years
5 Years
3 Years

-
23.76
25.29

P:BV (Average)

8 Years
5 Years
3 Years

-
5.06
5.03

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
18.59
19.20

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 324.41 332.01 -2.29% 409.71 355.37 15.29% 411.29 328.76 25.10% 314.58 282.14 11.50%
Expenses 249.98 205.62 21.57% 265.22 214.32 23.75% 255.79 202.57 26.27% 203.09 180.52 12.50%
EBITDA 74.43 126.39 -41.11% 144.49 141.05 2.44% 155.50 126.19 23.23% 111.49 101.62 9.71%
EBIDTM 22.94% 38.07% 35.27% 39.69% 37.81% 38.38% 35.44% 36.02%
Other Income 3.43 3.48 -1.44% 6.97 6.15 13.33% 4.03 3.37 19.58% 4.26 9.05 -52.93%
Interest 15.14 3.14 382.17% 6.54 7.49 -12.68% 6.84 7.23 -5.39% 2.96 0.98 202.04%
Depreciation 28.08 16.50 70.18% 25.00 15.90 57.23% 20.16 14.97 34.67% 17.28 15.07 14.66%
PBT 34.64 110.23 -68.57% 119.92 123.81 -3.14% 132.52 107.36 23.44% 95.51 94.63 0.93%
Tax 2.99 10.85 -72.44% 2.11 8.61 -75.49% 21.78 11.77 85.05% 7.67 7.92 -3.16%
PAT 31.66 99.38 -68.14% 117.81 115.20 2.27% 110.74 95.59 15.85% 87.84 86.71 1.30%
PATM 9.76% 29.93% 28.75% 32.42% 26.93% 29.08% 27.92% 30.73%
EPS 2.33 7.31 -68.13% 8.66 8.47 2.24% 8.14 7.03 15.79% 6.46 6.38 1.25%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 486.30 423.26 14.89% 505.30 460.51 9.73% 466.62 398.58 17.07% 402.80 305.95 31.66%
Expenses 310.79 286.06 8.65% 324.16 309.06 4.89% 296.88 269.38 10.21% 283.90 209.05 35.80%
EBITDA 175.51 137.20 27.92% 181.14 151.45 19.60% 169.75 129.20 31.39% 118.89 96.90 22.69%
EBIDTM 36.09% 32.42% 35.85% 32.89% 36.38% 32.42% 29.52% 31.67%
Other Income 4.20 2.24 87.50% 3.48 5.17 -32.69% 0.99 2.74 -63.87% 1.00 8.06 -87.59%
Interest 18.12 3.00 504.00% 16.29 7.07 130.41% 17.36 7.23 140.11% 8.87 1.26 603.97%
Depreciation 45.72 29.90 52.91% 42.09 28.62 47.06% 40.89 23.44 74.45% 35.13 18.36 91.34%
PBT 115.87 106.54 8.76% 126.24 120.93 4.39% 112.48 101.27 11.07% 75.90 85.34 -11.06%
Tax 14.41 6.31 128.37% 3.92 1.56 151.28% 18.84 8.20 129.76% 14.42 5.37 168.53%
PAT 101.46 100.23 1.23% 122.31 119.38 2.45% 93.65 93.08 0.61% 61.48 79.97 -23.12%
PATM 20.86% 23.68% 24.21% 25.92% 20.07% 23.35% 15.26% 26.14%
EPS 7.55 7.49 0.80% 9.07 8.85 2.49% 6.98 6.96 0.29% 4.81 5.91 -18.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,459.99 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 605.48 547.99 520.46 Net Sales Growth 12.46% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% 17.74% 10.49% 5.29% Cost Of Goods Sold 263.55 236.38 199.65 198.51 164.35 132.35 115.94 135.66 116.14 114.22 127.87 Gross Profit 1,196.44 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 489.33 433.76 392.59 GP Margin 81.95% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% 80.82% 79.15% 75.43% Total Expenditure 974.08 825.47 731.67 691.36 665.28 562.77 444.67 441.70 435.01 434.13 432.09 Power & Fuel Cost - 4.41 4.01 3.89 4.54 3.34 3.04 2.93 2.74 4.13 0.24 % Of Sales - 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% 0.45% 0.75% 0.05% Employee Cost - 252.52 220.11 207.02 191.73 166.77 130.84 116.31 122.36 123.75 87.85 % Of Sales - 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% 20.21% 22.58% 16.88% Manufacturing Exp. - 14.18 38.89 11.87 14.63 8.09 4.97 4.47 6.40 5.78 1.65 % Of Sales - 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% 1.06% 1.05% 0.32% General & Admin Exp. - 154.78 135.40 110.76 125.31 122.99 92.81 106.48 102.91 115.10 101.50 % Of Sales - 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% 17.00% 21.00% 19.50% Selling & Distn. Exp. - 137.77 98.34 109.88 131.07 125.15 95.36 72.99 82.35 70.47 112.74 % Of Sales - 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% 13.60% 12.86% 21.66% Miscellaneous Exp. - 25.43 35.28 49.43 33.64 4.09 1.71 2.85 2.10 0.68 112.74 % Of Sales - 1.91% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% 0.35% 0.12% 0.04% EBITDA 485.91 505.25 484.06 417.47 354.95 333.77 315.93 271.20 170.47 113.86 88.37 EBITDA Margin 33.28% 37.97% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% 28.15% 20.78% 16.98% Other Income 18.69 17.26 28.99 10.00 15.49 32.50 28.22 25.08 3.28 3.43 4.36 Interest 31.48 20.95 3.05 0.94 1.97 22.90 10.48 0.85 0.28 0.01 0.06 Depreciation 90.52 64.66 51.45 37.64 44.88 31.59 21.79 21.44 19.55 14.67 3.75 PBT 382.59 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 88.92 Tax 34.55 38.90 41.35 38.29 32.32 26.39 18.23 25.84 15.96 19.28 23.40 Tax Rate 9.03% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% 10.37% 18.79% 26.32% PAT 348.05 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 65.53 PAT before Minority Interest 348.05 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 65.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.84% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% 22.79% 15.21% 12.59% PAT Growth -12.30% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% 79.85% 65.57% 27.16% EPS 25.59 29.27 30.68 25.78 21.42 20.98 21.59 18.25 10.14 6.13 4.82

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,861.02 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 597.02 545.56 508.82 Net Sales Growth 17.17% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% 25.54% 9.43% 7.22% Cost Of Goods Sold 334.62 352.35 258.51 238.27 171.53 153.70 141.57 133.60 98.48 99.73 98.73 Gross Profit 1,526.40 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 498.54 445.83 410.09 GP Margin 82.02% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% 83.50% 81.72% 80.60% Total Expenditure 1,215.73 1,148.23 862.01 781.11 706.17 637.08 533.49 480.36 425.32 424.10 409.87 Power & Fuel Cost - 5.70 4.16 3.95 4.62 3.45 3.17 3.02 3.59 4.89 1.32 % Of Sales - 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% 0.60% 0.90% 0.26% Employee Cost - 346.16 250.18 229.30 205.69 190.66 157.32 131.22 124.67 125.63 90.54 % Of Sales - 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% 20.88% 23.03% 17.79% Manufacturing Exp. - 15.61 38.81 11.51 13.96 7.81 4.89 5.05 7.87 6.78 3.67 % Of Sales - 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% 1.32% 1.24% 0.72% General & Admin Exp. - 206.62 154.21 121.70 135.85 142.38 116.86 121.29 104.36 115.43 101.84 % Of Sales - 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% 17.48% 21.16% 20.01% Selling & Distn. Exp. - 185.16 121.39 128.70 140.99 134.82 107.67 84.32 82.75 70.90 113.44 % Of Sales - 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% 13.86% 13.00% 22.29% Miscellaneous Exp. - 36.62 34.74 47.69 33.53 4.25 2.00 1.86 3.59 0.74 113.44 % Of Sales - 2.17% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% 0.60% 0.14% 0.07% EBITDA 645.29 536.92 485.03 430.75 367.89 345.08 322.11 269.14 171.70 121.46 98.95 EBITDA Margin 34.67% 31.86% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% 28.76% 22.26% 19.45% Other Income 9.67 11.15 26.09 8.71 16.01 31.69 26.41 25.11 3.37 3.49 4.42 Interest 60.64 26.34 4.22 1.98 2.30 23.06 10.65 1.10 0.28 0.02 0.28 Depreciation 163.83 117.09 64.70 42.98 50.26 36.35 25.64 22.76 20.36 15.51 4.77 PBT 430.49 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 98.33 Tax 51.59 30.48 36.41 39.36 34.84 26.21 17.25 23.78 19.59 20.16 27.41 Tax Rate 11.98% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% 12.68% 18.42% 27.88% PAT 378.90 382.16 406.11 355.13 296.50 290.80 294.11 246.79 133.57 89.23 70.79 PAT before Minority Interest 386.45 374.16 405.79 355.13 296.51 291.15 294.98 246.61 134.86 89.26 70.91 Minority Interest 7.55 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 -1.29 -0.03 -0.12 PAT Margin 20.36% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% 22.37% 16.36% 13.91% PAT Growth -3.50% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% 84.76% 49.69% 26.05% EPS 27.86 28.10 29.86 26.11 21.80 21.38 21.63 18.15 9.82 6.56 5.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 305.73 267.75 184.50 Share Capital 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 0.14 Total Reserves 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 305.59 267.61 184.36 Non-Current Liabilities 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 20.17 18.53 17.90 Secured Loans 209.47 0.00 0.00 0.00 0.00 273.69 0.00 0.00 0.50 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 31.03 28.84 29.14 24.13 16.47 15.02 19.80 23.10 19.99 17.02 Current Liabilities 361.73 249.79 212.42 203.06 360.46 277.88 114.26 70.81 64.30 64.99 Trade Payables 83.07 96.77 86.71 89.93 74.93 79.03 25.11 27.89 36.10 32.65 Other Current Liabilities 83.43 26.61 23.37 24.41 195.04 112.61 12.39 8.47 7.66 14.16 Short Term Borrowings 55.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 140.22 126.41 102.34 88.72 90.50 86.24 76.76 34.44 20.55 18.19 Total Liabilities 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 396.71 350.58 267.39 Net Block 897.81 642.00 584.32 600.64 483.85 489.75 91.78 64.79 61.27 63.85 Gross Block 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 108.20 85.52 73.47 Accumulated Depreciation 197.01 141.40 132.55 95.01 67.96 43.19 21.43 43.41 24.25 9.62 Non Current Assets 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 159.69 191.98 112.86 Capital Work in Progress 0.34 2.98 1.55 4.37 2.73 0.00 0.00 0.00 0.00 0.00 Non Current Investment 966.51 678.18 480.97 246.03 274.36 451.84 290.43 62.59 113.05 30.64 Long Term Loans & Adv. 85.95 11.13 25.36 15.44 16.00 10.95 12.19 32.30 17.66 18.36 Other Non Current Assets 7.17 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 0.00 Current Assets 630.03 663.56 491.60 503.22 619.60 383.86 266.61 237.02 158.60 154.53 Current Investments 30.00 99.55 50.40 74.27 306.11 93.76 90.18 143.73 69.24 66.96 Inventories 63.70 84.79 64.85 65.46 74.70 57.52 47.20 49.46 53.83 45.48 Sundry Debtors 229.22 137.56 113.76 140.82 75.90 60.50 41.30 25.36 23.62 22.31 Cash & Bank 47.65 46.10 32.66 64.95 6.47 8.81 2.06 8.53 4.91 5.90 Other Current Assets 259.46 20.97 25.70 48.25 156.42 163.28 85.87 9.94 7.00 13.86 Short Term Loans & Adv. 241.96 274.60 204.25 109.46 103.14 123.50 78.83 7.81 4.84 10.89 Net Current Assets 268.30 413.77 279.18 300.16 259.13 105.98 152.35 166.21 94.30 89.53 Total Assets 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91 396.71 350.58 267.39

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 299.62 266.04 176.88 Share Capital 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 0.14 Total Reserves 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 299.49 265.91 176.74 Non-Current Liabilities 729.49 -78.80 -109.06 -79.63 -65.50 248.09 11.82 19.84 18.52 17.88 Secured Loans 644.45 45.00 0.00 0.00 0.29 274.19 0.49 0.00 0.50 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 44.13 32.16 31.47 25.98 19.39 18.71 22.96 23.10 19.99 17.02 Current Liabilities 521.18 283.34 235.45 220.17 377.25 293.98 129.27 68.95 65.49 71.27 Trade Payables 124.77 117.77 102.62 100.05 84.13 90.77 38.52 24.57 36.71 37.38 Other Current Liabilities 190.12 35.81 29.07 27.44 198.57 115.06 13.52 9.71 7.74 14.77 Short Term Borrowings 55.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 151.29 129.75 103.76 92.68 94.55 88.15 77.24 34.67 21.04 19.12 Total Liabilities 3,471.35 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 391.61 353.97 270.39 Net Block 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 71.37 71.74 74.92 Gross Block 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 123.31 103.73 91.43 Accumulated Depreciation 275.07 174.02 151.92 109.04 77.73 48.42 22.78 51.95 31.99 16.50 Non Current Assets 2,628.68 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 169.38 190.50 114.91 Capital Work in Progress 21.72 26.99 1.55 4.37 2.73 0.00 0.07 0.00 0.00 0.00 Non Current Investment 6.69 420.84 243.65 3.20 40.91 271.61 213.05 62.60 97.28 17.00 Long Term Loans & Adv. 24.79 35.94 25.90 16.47 17.03 12.11 12.84 35.41 21.48 22.98 Other Non Current Assets 7.37 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 0.00 Current Assets 842.67 711.02 535.56 535.10 653.49 367.23 269.50 222.24 163.48 155.48 Current Investments 30.01 99.55 50.40 74.78 314.94 93.76 90.18 127.44 69.24 66.96 Inventories 131.44 117.91 94.47 69.47 82.65 65.45 55.82 47.62 57.60 44.81 Sundry Debtors 292.71 160.97 140.49 156.88 83.98 66.64 48.86 25.37 23.67 22.34 Cash & Bank 58.46 52.33 38.28 67.33 7.51 10.64 2.42 9.69 5.72 7.29 Other Current Assets 330.07 24.04 36.24 55.15 164.41 130.74 72.22 12.11 7.25 14.08 Short Term Loans & Adv. 307.65 256.23 175.70 111.48 106.85 86.48 64.91 9.85 4.97 11.05 Net Current Assets 321.49 427.68 300.12 314.93 276.24 73.25 140.22 153.29 97.98 84.21 Total Assets 3,471.35 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02 391.62 353.98 270.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 322.33 369.41 395.41 265.25 216.31 236.28 209.72 132.65 92.37 89.69 PBT 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 88.92 Adjustment 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 17.81 11.35 -0.49 Changes in Working Capital -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 -7.53 1.42 27.48 Cash after chg. in Working capital 400.11 452.31 463.44 315.59 286.17 303.95 261.92 164.21 115.37 115.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 -31.55 -23.00 -26.23 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 -45.39 -94.36 -84.64 Net Fixed Assets -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 -52.56 Net Investments -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 -39.55 Others 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 1.32 2.38 7.47 Cash from Financing Activity 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 -83.70 0.99 -0.43 Net Cash Inflow / Outflow 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 3.57 -1.00 4.63 Opening Cash & Equivalents 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 5.90 1.28 Closing Cash & Equivalent 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 5.90

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 291.74 378.26 375.36 271.17 223.00 234.63 200.21 131.48 90.06 89.62 PBT 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 98.33 Adjustment 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 19.92 12.15 0.69 Changes in Working Capital -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 -8.21 -8.06 20.73 Cash after chg. in Working capital 368.95 461.55 443.90 322.94 294.62 304.20 253.29 166.16 113.50 119.74 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 -34.68 -23.44 -30.11 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 -43.91 -92.13 -82.74 Net Fixed Assets -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 -52.56 Net Investments -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 -39.55 Others -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 2.80 4.61 9.37 Cash from Financing Activity 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 -83.70 0.46 -2.30 Net Cash Inflow / Outflow -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 3.87 -1.62 4.58 Opening Cash & Equivalents 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 6.62 2.04 Closing Cash & Equivalent 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 6.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 163.18 141.00 115.74 95.51 83.97 63.14 41.79 22154.28 19402.10 13369.28 ROA 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% 36.93% 26.97% 29.71% ROE 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% 48.12% 36.85% 43.19% ROCE 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% 53.64% 45.28% 58.57% Fixed Asset Turnover 1.46 1.67 1.61 1.64 1.65 2.35 6.44 6.43 7.01 11.03 Receivable days 48.81 36.56 40.89 38.77 27.76 24.43 17.07 14.34 15.05 13.64 Inventory Days 19.76 21.77 20.93 25.07 26.92 25.13 24.74 30.25 32.55 34.17 Payable days 138.85 167.72 162.39 56.42 58.45 51.57 30.40 33.54 37.94 29.28 Cash Conversion Cycle -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 11.05 9.66 18.54 Total Debt/Equity 0.14 0.00 0.00 0.00 0.15 0.43 0.00 0.00 0.00 0.00 Interest Cover 21.85 151.29 416.49 165.51 14.61 30.77 321.83 556.69 0.00 1435.24

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 161.28 140.25 115.81 95.26 83.58 62.64 41.25 21711.81 19278.55 12817.54 ROA 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% 36.17% 28.59% 32.09% ROE 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% 47.68% 40.30% 50.12% ROCE 17.31% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% 54.56% 49.25% 68.93% Fixed Asset Turnover 0.90 1.33 1.25 1.18 1.18 1.59 3.97 5.42 5.68 7.82 Receivable days 46.91 39.44 43.59 40.93 27.99 24.64 18.07 14.56 15.14 13.97 Inventory Days 25.78 27.78 24.03 25.85 27.52 25.87 25.19 31.24 33.71 31.57 Payable days 125.63 155.58 155.23 59.47 59.07 54.07 32.17 33.59 41.33 35.37 Cash Conversion Cycle -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 12.21 7.52 10.16 Total Debt/Equity 0.38 0.02 0.00 0.00 0.15 0.44 0.00 0.00 0.00 0.00 Interest Cover 16.36 105.81 200.75 145.25 14.76 30.31 246.14 558.56 4974.41 358.55

Top Investors:

emerald investments limited

hdfc small cap fund

uti flexi cap fund

bhikhalal chimanlal shah

hetal rasiklal shah

franklin india smaller companies fund

Annual Reports:

News Update:

Eris Lifesciences acquires Biocon Biologics’ India branded formulation business
15th Mar 2024, 10:59 AM

The acquisition brings two major insulin brands - Basalog and Insugen - into the Eris fold
Read More
Eris Lifesciences acquires 51% stake in Swiss Parenterals
16th Feb 2024, 11:53 AM

The cost of acquisition is Rs 637.50 crore
Read More
Eris Lifesciences - Quarterly Results
13th Feb 2024, 15:35 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback